Imam Khomeini Hospital or also Hezar Takhtkhabi Hospital Center is a teaching hospital complex and biomedical research facility of Tehran University of Medical Sciences, located in Tehran, Iran..
Introduction: The outbreak of COVID-19 was reported first in China. A COVID-19 infection can lead to severe infection, sustained inflammation, fibrosis, increased intensive care unit admissions, and mortality rates. Objectives: This study evaluates the relationship between body mass index (BMI) and disease severity in COVID-19 patients admitted from April to September 2020 at Imam Khomeini Hospital Center. Patients and Methods: Our study included a cross-sectional analysis of patients. We included 120 hospitalized adults (aged over 18 years) from April to September 2020. COVID-19 patients were defined as those with moderate to severe common symptoms (fever or chills, fatigue, and cough) as well as SARS-CoV-2 infection confirmed by reverse transcription polymerase chain reaction (RT-PCR). The BMI measurement was conducted based on the first BMI value listed following admission. Results: In patients without underlying disease (51 patients), BMI significantly correlates with lymphocyte count and patients taking remdesivir. In patients with underlying disease (69 patients), BMI significantly correlates with age, temperature, hemoptysis, intensive care unit admission, and taking remdesivir. In all patients (120 patients), BMI significantly correlates with age, intensive care unit admission, and taking remdesivir. Additionally, the correlation of hemoptysis with BMI is greater than dry cough and productive cough. Conclusion: This study highlights the higher risk of intensive care unit admission and taking remdesivir due to severe COVID-19 in obese patients. Clinical practitioners should pay more attention to obese patients and treat them more aggressively and promptly. Therefore, lifestyle modification seems to be effective. Further studies are required to illustrate better whether obesity is a significant independent risk factor for COVID-19.
To evaluate an AI-based decision-support system for mammography interpretation, assessing its impact on diagnostic performance. This retrospective study analyzed 130,838 mammograms from 35,709 patients with confirmed follow-up outcomes across multiple centers, using the Digital Database for Screening Mammography (DDSM) for external validation. Representing one of the largest datasets from the Middle East, it evaluates model generalizability in underrepresented populations. An AI super-model incorporated separate UNet-based networks for lesion segmentation, a high-resolution model (4096) for calcifications, a multi-resolution ensemble (4096, 2048, 1024) for macro-scale lesions, and a risk-assessment model for malignancy prediction. Radiologists interpreted images under five scenarios: unaided, AI-assisted, AI as the final decision-maker in uncertain cases, union of radiologist and AI decisions in uncertain cases, and standalone AI. AI assistance significantly enhanced performance across all scenarios. Based on aggregated reader performance, AUC improved from 83.04
Opportunistic pathogens such as Acanthamoeba spp., Microsporidia, and Pneumocystis jirovecii are well recognized causes of pulmonary infections in immunocompromised patients. However, their prevalence and clinical significance in immunocompetent individuals with respiratory disorders remain poorly understood. This study aimed to determine the presence of Acanthamoeba spp., Microsporidia, and P. jirovecii in bronchoalveolar lavage (BAL) samples from immunocompetent patients with various respiratory disorders referred to the Iranian National Registry Center for Lophomoniasis (INRCL) at Imam Khomeini Hospital, Mazandaran province, northern Iran. This cross-sectional study analyzed 146 BAL samples collected from immunocompetent patients with respiratory disorders during 2024. DNA was extracted using a phenol-chloroform-isoamyl alcohol method. Molecular detection was performed using conventional PCR with genus-specific primers (JDP1/JDP2) for Acanthamoeba spp., and nested PCR assays targeting the ITS region for Microsporidia and the mitochondrial large subunit rRNA (mtLSU rRNA) gene for P. jirovecii. Genotype identification of Acanthamoeba isolates was achieved through bidirectional Sanger sequencing, and sequences were analyzed using BLASTn. A phylogenetic tree was constructed using MEGA-x software employing the Maximum Likelihood method with the Tamura 3-parameter model and 1,000 bootstrap replicates. Statistical analysis was performed using the Chi-square test (SPSS v20), with a P-value < 0.05 considered statistically significant. Molecular analysis identified Acanthamoeba spp. in six cases (4.11%), which were classified as genotypes T4 (n = 5) and T5 (n = 1). All six patients had underlying chronic respiratory conditions, with chronic cough as the predominant symptom. Additionally, P. jirovecii was detected in nine patients (6.16%), including one case of co-detection with Acanthamoeba T4. Among P. jirovecii-positive cases, the majority resided in rural areas, and all had pre-existing pulmonary diseases. Microsporidia genus were not detected in any of the samples analyzed, which may reflect their low prevalence in immunocompetent populations or possible methodological limitations. Molecular detection of Acanthamoeba (primarily genotype T4) and P. jirovecii DNA in BAL specimens from immunocompetent patients with underlying chronic lung diseases indicates the presence of these organisms in the respiratory tract. The relatively higher detection rate of P. jirovecii among rural residents warrants further epidemiological investigation. Importantly, PCR positivity alone should not be interpreted as definitive evidence of clinical disease, and the significance of these molecular findings requires careful clinical correlation. Future prospective studies with longitudinal follow-up are needed to determine whether these colonizers contribute to disease progression or exacerbation in immunocompetent individuals with pre-existing pulmonary conditions.
Abstract Background Elevated admission blood glucose is associated with higher mortality in acute myocardial infarction (AMI). However, it does not distinguish stress-induced hyperglycemia (SIH) from chronic hyperglycemia, particularly in diabetic patients. The stress hyperglycemia ratio (SHR), calculated as admission blood glucose divided by estimated average glucose from glycated hemoglobin, offers a more accurate marker of stress hyperglycemia independent of baseline glycemic status. This systematic review and meta-analysis assessed the prognostic value of SHR for adverse outcomes in patients with acute coronary syndrome (ACS). Methods We systematically searched PubMed, EMBASE, Web of Science, and Scopus from inception to January 2026. Observational cohort studies of ACS patients were included. The primary outcome was all-cause mortality. Secondary outcomes included major adverse cardiovascular events (MACE), cardiovascular mortality, recurrent myocardial infarction (MI), stroke, heart failure (HF), and revascularization. SHR was analyzed as both continuous and categorical variables. Hazard ratios (HRs) for the highest versus lowest SHR categories or per 1-unit increase were pooled using random-effects models with 95% confidence intervals (CIs). Subgroup analyses were performed according to diabetes status. Results Thirty-five studies involving 167,575 participants (mean age 64.4 years, 73.6% male) were included. Higher SHR was strongly associated with increased all-cause mortality (HR: 1.68, 95% CI: 1.52–1.85, p < 0.0001, I² = 0%). Similar association persisted in continuous analyses (HR: 1.39 per unit, 95% CI: 1.06–1.81, p < 0.0001, I² = 86.3%). The highest SHR category was also linked to elevated risks of MACE (HR: 1.55, 95% CI: 1.34–1.79, p < 0.00001, I² = 80.7%), cardiovascular mortality (HR: 1.74, 95% CI: 1.19–2.55, p = 0.004, I² = 84.6%), stroke (HR: 1.73, 95% CI: 1.15–2.60, p = 0.009, I² = 0%), and HF (HR: 1.71, 95% CI: 1.39–2.11, p < 0.0001, I² = 6.6%). Risks of revascularization and recurrent MI did not differ significantly across SHR categories. Associations remained consistent in continuous analyses. The relationship between higher SHR and mortality was consistent across diabetes subgroups. Increased mortality risk was observed among patients with diabetes (HR: 1.52, 95% CI: 1.18–1.95, p = 0.0347, I2 = 61.4%) and those without diabetes (HR: 1.84, 95% CI: 1.45–2.34, p = 0.0846, I2 = 51.2%), with no significant subgroup differences (p for interaction = 0.27). Conclusion SHR offers incremental prognostic value in ACS patients and may serve as a simple, widely available tool for risk stratification independent of diabetes status. Further research is needed to clarify its clinical utility.
Sleep quality is a critical but understudied factor in heart failure (HF) self‑care. This cross‑sectional study investigated the association between sleep quality and self‑care behaviours in 309 patients with chronic heart failure hospitalized in cardiology wards at Imam Khomeini Hospital, Ardabil, Iran, in 2025. Data were collected using the Hippocratic Heart Failure Self-Care Scale (HHFSCS) and the Sleep Quality Scale for Coronary Care Patients (SQ-CC). Poor sleep quality was significantly associated with lower self-care scores (r = − 0.51, p < 0.001). Hierarchical regression showed that adding sleep quality explained an additional 10.1% of variance in self-care (ΔR² = 0.101, p < 0.001) beyond demographic and clinical factors (overall R² = 0.521). Sleep quality is significantly associated with self-care in heart failure patients. Although the cross-sectional design limits causal inference, these findings suggest that sleep quality may be a modifiable factor worth considering in future interventions designed to improve self-care.